Publication | Closed Access

Haplogroup analysis of the risk associated with APOE promoter polymorphisms (−219T/G, −491A/T and −427T/C) in Colombian Alzheimer's disease patients

Neurodegenerative DiseasesAlzheimer's DiseaseApoe Promoter PolymorphismsGenetic EpidemiologyVascular DementiaHaplogroup AnalysisNeuroscienceNeurologyNeurodegenerationColombian AlzheimerPublic HealthMedicineAging-associated DiseaseRisk FactorsEpidemiologyProtective Mechanisms